Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Kusi, Kwadwo A ^a   Bosomprah, Samuel ^b   Dodoo, Daniel ^a   Kyei Baafour, Eric ^a   Dickson, Emmanuel K ^a   Mensah, Daniel ^a   Angov, Evelina ^c   Dutta, Sheetij ^c   Sedegah, Martha ^d   Koram, Kwadwo A ^a  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Antibody seroconversion rate; ELISA; Malaria; Seroreversion rate; Sporozoite antigens; Transmission intensity

Indexed keywords

AMA1 ANTIGEN; CELTOS ANTIGEN; CSP ANTIGEN; PARASITE ANTIBODY; PARASITE ANTIGEN; SPOROZOITE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; COMPARATIVE STUDY; DISEASE MARKER; HUMAN; MAJOR CLINICAL STUDY; MALARIA; PLASMODIUM FALCIPARUM; SEROCONVERSION; SEROPREVALENCE; SPOROZOITE;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; FEMALE; GHANA; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; SEROEPIDEMIOLOGIC STUDIES; SPOROZOITES; YOUNG ADULT;

EID: 84899118678     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-103     Document Type: Article

References (43)

1. WHO, World malaria report Geneva, Switzerland: WHO Press, World Health Organization 2012
2. Evaluation of light microscopy and rapid diagnostic test for the detection of malaria under operational field conditions: a household survey in Ethiopia. Endeshaw T, Gebre T, Ngondi J, Graves PM, Shargie EB, Ejigsemahu Y, Ayele B, Yohannes G, Teferi T, Messele A, Zerihun M, Genet A, Mosher AW, Emerson PM, Richards FO, Malar J 2008 7 118
3. Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania. Oesterholt MJ, Bousema JT, Mwerinde OK, Harris C, Lushino P, Masokoto A, Mwerinde H, Mosha FW, Drakeley CJ, Malar J 2006 5 98
4. An estimation of the entomological inoculation rate for Ifakara: a semi-urban area in a region of intense malaria transmission in Tanzania. Drakeley C, Schellenberg D, Kihonda J, Sousa CA, Arez AP, Lopes D, Lines J, Mshinda H, Lengeler C, Armstrong SJ, Tanner M, Alonso P, Trop Med Int Health 2003 8 767 774
5. Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Mbogo CM, Mwangangi JM, Nzovu J, Gu W, Yan G, Gunter JT, Swalm C, Keating J, Regens JL, Shililu JI, Githure JI, Beier JC, Am J Trop Med Hyg 2003 68 734 742
6. Serology: a robust indicator of malaria transmission intensity? Corran P, Coleman P, Riley E, Drakeley C, Trends Parasitol 2007 23 575 582
7. Parasite prevalence: a static measure of dynamic infections. O'Meara WP, Collins WE, McKenzie FE, Am J Trop Med Hyg 2007 77 246 249
8. Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Bousema T, Youssef RM, Cook J, Cox J, Alegana VA, Amran J, Noor AM, Snow RW, Drakeley C, Emerg Infect Dis 2010 16 392 399
9. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM, Proc Natl Acad Sci U S A 2005 102 5108 5113
10. Rapid assessment of malaria transmission using age-specific sero-conversion rates. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, Masika P, Mosha J, Bousema T, Shekalaghe S, Cook J, Corran P, Ghani A, Riley EM, Drakeley C, PLoS ONE 2009 4 6083
11. Low cellular response in vitro among subjects with long-term exposure to malaria transmission in Brazilian endemic areas. Braga EM, Carvalho LH, Fontes CJ, Krettli AU, Am J Trop Med Hyg 2002 66 299 303
12. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity. Morais CG, Soares IS, Carvalho LH, Fontes CJ, Krettli AU, Braga EM, Am J Trop Med Hyg 2006 75 582 587
13. Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Druilhe P, Pradier O, Marc JP, Miltgen F, Mazier D, Parent G, Infect Immun 1986 53 393 397
14. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Doolan DL, Southwood S, Freilich DA, Sidney J, Graber NL, Shatney L, Bebris L, Florens L, Dobano C, Witney AA, Appella E, Hoffman SL, Yates JR III, Carucci DJ, Sette A, Proc Natl Acad Sci U S A 2003 100 9952 9957
15. Differential transcriptome profiling identifies Plasmodium genes encoding pre-erythrocytic stage-specific proteins. Kaiser K, Matuschewski K, Camargo N, Ross J, Kappe SH, Mol Microbiol 2004 51 1221 1232
16. CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Kariu T, Ishino T, Yano K, Chinzei Y, Yuda M, Mol Microbiol 2006 59 1369 1379
17. Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint. Porter MD, Nicki J, Pool CD, DeBot M, Illam RM, Brando C, Bozick B, De La Vega P, Angra D, Spaccapelo R, Crisanti A, Murphy JR, Bennett JW, Schwenk RJ, Ockenhouse CF, Dutta S, Clin Vaccine Immunol 2013 20 803 810
18. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei. Bergmann-Leitner ES, Mease RM, De La Vega P, Savranskaya T, Polhemus M, Ockenhouse C, Angov E, PLoS ONE 2010 5 12294
19. Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli. Dutta S, Ware LA, Barbosa A, Ockenhouse CF, Lanar DE, Infect Immun 2001 69 5464 5470
20. High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model. Dutta S, Sullivan JS, Grady KK, Haynes JD, Komisar J, Batchelor AH, Soisson L, Diggs CL, Heppner DG, Lanar DE, Collins WE, Barnwell JW, PLoS ONE 2009 4 8138
21. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Corran PH, Cook J, Lynch C, Leendertse H, Manjurano A, Griffin J, Cox J, Abeku T, Bousema T, Ghani AC, Drakeley C, Riley E, Malar J 2008 7 195
22. Maximum likelihood for parasitologists. Williams BG, Dye C, Parasitol Today 1994 10 489 493
23. Identification of hot spots of malaria transmission for targeted malaria control. Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, Mosha F, Otieno S, Carneiro I, Cox J, Msuya E, Kleinschmidt I, Maxwell C, Greenwood B, Riley E, Sauerwein R, Chandramohan D, Gosling R, J Infect Dis 2010 201 1764 1774
24. Using serological measures to monitor changes in malaria transmission in Vanuatu. Cook J, Reid H, Iavro J, Kuwahata M, Taleo G, Clements A, McCarthy J, Vallely A, Drakeley C, Malar J 2010 9 169
25. Long-lived antibody and B cell memory responses to the human malaria parasites, plasmodium falciparum and plasmodium vivax. Wipasa J, Suphavilai C, Okell LC, Cook J, Corran PH, Thaikla K, Liewsaree W, Riley EM, Hafalla JC, PLoS Pathog 2010 6 1000770
26. Persistence of humoral response against sporozoite and blood-stage malaria antigens 7 years after a brief exposure to Plasmodium vivax. Braga EM, Fontes CJ, Krettli AU, J Infect Dis 1998 177 1132 1135
27. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Dodoo D, Hollingdale MR, Anum D, Koram KA, Gyan B, Akanmori BD, Ocran J, Adu-Amankwah S, Geneshan H, Abot E, Legano J, Banania G, Sayo R, Brambilla D, Kumar S, Doolan DL, Rogers WO, Epstein J, Richie TL, Sedegah M, Malar J 2011 10 168
28. Acquired immunity to malaria. Doolan DL, Dobano C, Baird JK, Clin Microbiol Rev 2009 22 13 36
29. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Baird JK, Parasitol Today 1995 11 105 111
30. Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania. Shekalaghe S, Alifrangis M, Mwanziva C, Enevold A, Mwakalinga S, Mkali H, Kavishe R, Manjurano A, Sauerwein R, Drakeley C, Bousema T, BMC Infect Dis 2009 9 69
31. Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. Drakeley CJ, Carneiro I, Reyburn H, Malima R, Lusingu JP, Cox J, Theander TG, Nkya WM, Lemnge MM, Riley EM, J Infect Dis 2005 191 1589 1598
32. Toward a surrogate marker of malaria exposure: modeling longitudinal antibody measurements under outbreak conditions. Campo JJ, Whitman TJ, Freilich D, Burgess TH, Martin GJ, Doolan DL, PLoS ONE 2011 6 21826
33. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka. Ramasamy R, Nagendran K, Ramasamy MS, Am J Trop Med Hyg 1994 50 537 547
34. Circumsporozoite antibody as a serologic marker of Plasmodium falciparum transmission. Webster HK, Gingrich JB, Wongsrichanalai C, Tulyayon S, Suvarnamani A, Sookto P, Permpanich B, Am J Trop Med Hyg 1992 47 489 497
35. Malaria infection, morbidity and transmission in two ecological zones in Southern Ghana. Afari EA, Appawu M, Dunyo S, Baffoe-Wilmot A, Nkrumah FK, Afr J Health Sci 1995 2 312 315
36. Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana. Agyepong IA, Ansah E, Gyapong M, Adjei S, Barnish G, Evans D, Soc Sci Med 2002 55 2215 2226
37. Mosquito avoidance and bed net use in the greater Accra region, Ghana. Agyepong IA, Manderson L, J Biosoc Sci 1999 31 79 92
38. Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Ansah EK, Gyapong JO, Agyepong IA, Evans DB, Trop Med Int Health 2001 6 496 504
39. Effect of removing direct payment for health care on utilisation and health outcomes in Ghanaian children: a randomised controlled trial. Ansah EK, Narh-Bana S, Asiamah S, Dzordzordzi V, Biantey K, Dickson K, Gyapong JO, Koram KA, Greenwood BM, Mills A, Whitty CJ, PLoS Med 2009 6 1000007
40. Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Chinbuah AM, Gyapong JO, Pagnoni F, Wellington EK, Gyapong M, Trop Med Int Health 2006 11 1003 1016
41. Dodowa Health Research Centre, 2008-2009 Biennial report 2009 1 40
42. th October 2013.
43. Total and putative surface proteomics of malaria parasite salivary gland sporozoites. Lindner SE, Swearingen KE, Harupa A, Vaughan AM, Sinnis P, Moritz RL, Kappe SH, Mol Cell Proteomics 2013 12 1127 1143